MedPath

FODMAPs and Refractory GERD

Not Applicable
Completed
Conditions
Gastro-esophageal Reflux Disease (GERD)
Interventions
Dietary Supplement: GERD diet
Dietary Supplement: Low-FODMAP diet
Registration Number
NCT02471989
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

The aim of this study is to determine the effects of a low Fermentescible Oligosaccharides Disaccharides Monosaccharides and Polyols (FODMAP) diet in patients with documented refractory GERD on proton pump inhibitor (PPI) therapy.

Detailed Description

Colonic fermentation has been shown to influence oeso-gastric motility : increased gastric relaxation, increased rate of lower esophageal sphincter relaxation. Experimental increased colonic fermentation (FOS in diet) increase the occurrence of reflux events in patients with GERD. The aim of this study is to compare the low-FODMAP diet and classical GERD dietary recommendations (avoid fatty meals, head of bed elevation etc..) in patients with refractory GERD symptoms.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • Age > 18
  • Affiliation to French Social Security
  • Informed written consent
  • RDQ score > 3
  • Abnormal pH-impedance monitoring on PPI twice daily (since 3 months) according to normal values published by Zerbib et al (CGH 2013)
Exclusion Criteria
  • Pregnancy or breast feeding
  • Women of childbearing potential without an effective method of contraception
  • Person under guardianship
  • History of thoracic of abdominal surgery (excepted appendectomy and cholecystectomy)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Classical GERD dietGERD dietavoid fatty meals, head of bed elevation...
Low-FODMAP dietLow-FODMAP dietFOS in diet
Primary Outcome Measures
NameTimeMethod
Percentage of patients with clinical remission as defined by a RDQ score ≤ 3at Week 4 of diet
Secondary Outcome Measures
NameTimeMethod
Between-group comparison of efficacyat Week 4 of diet

This measure is a composite with :

* Reflux Disease Questionnaire (RDQ) scores

* Francis Irritable Bowel Syndrome (IBS) score

* Quality of life (GIQLI) score

* and reflux parameter on pH-impedance monitoring

Trial Locations

Locations (4)

Explorations fonctionnelles

🇫🇷

Lyon, France

Explorations fonctionnelles Digestives

🇫🇷

Rennes, France

Gastroentérologie

🇫🇷

Rouen, France

Hépato-Gastroentérologie et oncologie digestive,

🇫🇷

Bordeaux, France

© Copyright 2025. All Rights Reserved by MedPath